X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (35179) 35179
Publication (2898) 2898
Book Chapter (255) 255
Book Review (255) 255
Dissertation (124) 124
Conference Proceeding (80) 80
Magazine Article (29) 29
Book / eBook (18) 18
Reference (14) 14
Newsletter (8) 8
Web Resource (6) 6
Government Document (2) 2
Paper (2) 2
Trade Publication Article (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (21096) 21096
male (13056) 13056
humans (10642) 10642
rats (10483) 10483
index medicus (7221) 7221
neurosciences (6636) 6636
female (6540) 6540
pharmacology & pharmacy (6461) 6461
receptors, muscarinic - metabolism (6261) 6261
receptors, muscarinic - drug effects (5352) 5352
muscarinic receptors (5071) 5071
muscarinic antagonists - pharmacology (4212) 4212
acetylcholine (4137) 4137
in vitro techniques (4090) 4090
mice (3754) 3754
receptors, muscarinic - physiology (3731) 3731
carbachol - pharmacology (3559) 3559
dose-response relationship, drug (3185) 3185
biochemistry & molecular biology (3026) 3026
atropine - pharmacology (2964) 2964
muscarinic agonists - pharmacology (2853) 2853
muscarinic receptor (2705) 2705
rats, sprague-dawley (2636) 2636
rats, wistar (2465) 2465
physiology (2345) 2345
middle aged (2314) 2314
adult (2219) 2219
receptors (2192) 2192
muscarinic antagonists - therapeutic use (2170) 2170
acetylcholine - pharmacology (2004) 2004
guinea pigs (1950) 1950
aged (1949) 1949
kinetics (1876) 1876
brain (1836) 1836
calcium - metabolism (1692) 1692
time factors (1686) 1686
rat (1680) 1680
activation (1579) 1579
acetylcholine - metabolism (1577) 1577
rats, inbred strains (1574) 1574
neurons (1550) 1550
muscle contraction - drug effects (1461) 1461
cells, cultured (1436) 1436
brain - metabolism (1390) 1390
signal transduction (1388) 1388
muscle, smooth - drug effects (1379) 1379
muscarinic antagonists - administration & dosage (1375) 1375
binding (1370) 1370
electric stimulation (1350) 1350
cell biology (1322) 1322
quinuclidinyl benzilate - metabolism (1318) 1318
acetylcholine receptors (1290) 1290
muscarinic antagonists (1272) 1272
muscarinic (1268) 1268
alzheimers-disease (1260) 1260
cells (1230) 1230
research (1223) 1223
analysis (1211) 1211
expression (1188) 1188
article (1138) 1138
hippocampus (1127) 1127
atropine (1119) 1119
treatment outcome (1104) 1104
neurons - drug effects (1070) 1070
physiological aspects (1067) 1067
inhibition (1056) 1056
urology & nephrology (1054) 1054
rabbits (1044) 1044
receptors, muscarinic - genetics (1042) 1042
scopolamine (1041) 1041
disease models, animal (1038) 1038
pirenzepine - pharmacology (1038) 1038
ligands (1007) 1007
muscarinic acetylcholine-receptor (1004) 1004
cell line (987) 987
myocardium - metabolism (986) 986
subtypes (969) 969
carbachol (961) 961
overactive bladder (946) 946
memory (942) 942
receptor (935) 935
radioligand assay (927) 927
psychiatry (918) 918
parasympatholytics - pharmacology (912) 912
phosphorylation (902) 902
oxotremorine - pharmacology (890) 890
rat-brain (884) 884
gtp-binding proteins - metabolism (883) 883
hippocampus - drug effects (880) 880
proteins (871) 871
calcium (869) 869
muscarinic antagonists - adverse effects (869) 869
brain - drug effects (861) 861
binding, competitive (857) 857
muscarinic acetylcholine-receptors (855) 855
cricetinae (852) 852
acetylcholine-receptors (847) 847
neurons - metabolism (847) 847
chemistry, medicinal (835) 835
structure-activity relationship (833) 833
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (14) 14
Online Resources - Online (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Faculty of Information - Stacks (1) 1
Gerstein Science - Theses (1) 1
Robarts - Stacks (1) 1
Royal Ontario Museum - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (34034) 34034
Russian (357) 357
Japanese (294) 294
German (205) 205
Chinese (200) 200
French (134) 134
Spanish (80) 80
Polish (30) 30
Korean (29) 29
Italian (28) 28
Portuguese (23) 23
Czech (15) 15
Ukrainian (15) 15
Dutch (12) 12
Danish (10) 10
Romanian (8) 8
Swedish (7) 7
Hebrew (5) 5
Norwegian (5) 5
Slovak (5) 5
Finnish (4) 4
Serbian (4) 4
Turkish (4) 4
Bulgarian (3) 3
Hungarian (3) 3
Persian (3) 3
Croatian (2) 2
Lithuanian (2) 2
Bosnian (1) 1
Greek (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Naunyn-Schmiedeberg's Archives of Pharmacology, ISSN 0028-1298, 4/2009, Volume 379, Issue 4, pp. 389 - 395
Journal Article
Neuroscience, ISSN 0306-4522, 2010, Volume 169, Issue 4, pp. 1610 - 1620
Abstract We have shown that cortical acetylcholine modulates the balance between excitation and inhibition evoked in layer 5 pyramidal neurons of rat visual... 
Neurology | pyramidal neuron | acetylcholine | M1- M2- M3- M4- M5-muscarinic receptors | cortical network | Acetylcholine | Cortical network | Pyramidal neuron | GABAERGIC TRANSMISSION | SYNAPTIC-TRANSMISSION | NEUROSCIENCES | ACETYLCHOLINE-RECEPTOR | CEREBRAL-CORTEX | IN-VITRO | CORTICAL-NEURONS | M1-M2-M3-M4-M5-muscarinic receptors | AUDITORY-CORTEX | CHOLINERGIC MODULATION | POSTNATAL-DEVELOPMENT | HIPPOCAMPAL PYRAMIDAL CELLS | Pyramidal Cells - metabolism | Rats, Wistar | Receptor, Muscarinic M4 - physiology | Receptor, Muscarinic M1 - antagonists & inhibitors | Receptor, Muscarinic M3 - physiology | Receptors, Muscarinic - metabolism | Receptor, Muscarinic M1 - physiology | Excitatory Postsynaptic Potentials - drug effects | Receptor, Muscarinic M2 - physiology | Visual Cortex - physiology | Excitatory Postsynaptic Potentials - physiology | Neural Inhibition - physiology | Muscarinic Antagonists - pharmacology | Pyramidal Cells - physiology | Receptor, Muscarinic M2 - antagonists & inhibitors | Glutamic Acid - secretion | Pyramidal Cells - drug effects | Organ Culture Techniques | Inhibitory Postsynaptic Potentials - physiology | Rats | Receptor, Muscarinic M3 - antagonists & inhibitors | Animals | Glutamic Acid - metabolism | Visual Cortex - drug effects | Neural Inhibition - drug effects | Receptor, Muscarinic M4 - antagonists & inhibitors | Inhibitory Postsynaptic Potentials - drug effects | Receptors, Muscarinic - physiology | Methyl aspartate | Cell research | Neurosciences | Neurons | GABA | Glutamate | Benzodiazepines | Acetylcholine receptors (muscarinic) | Neural Inhibition | Neurons and Cognition | Visual Cortex | Muscarinic Antagonists | Receptor, Muscarinic M1 | Receptor, Muscarinic M2 | Receptor, Muscarinic M3 | Receptor, Muscarinic M4 | Glutamic Acid | Life Sciences | Receptors, Muscarinic | Excitatory Postsynaptic Potentials | Pyramidal Cells | Inhibitory Postsynaptic Potentials
Journal Article
Pharmacology and Therapeutics, ISSN 0163-7258, 2008, Volume 117, Issue 2, pp. 232 - 243
Muscarinic acetylcholine receptors (mAChRs) are widely expressed in the CNS where they control a variety of neuronal functions. Due to their roles in a number... 
Parkinson's disease | mAChR | Schizophrenia | CNS | Drug dependence | Muscarinic receptors | Alzheimer's disease | AFFINITY AGONIST BINDING | ALZHEIMERS-DISEASE | schizophrenia | AMYLOID PRECURSOR PROTEIN | SUBSTANTIA-NIGRA | drug dependence | PEDUNCULOPONTINE TEGMENTAL NUCLEUS | muscarinic receptors | EXPERIMENTAL CHOLINERGIC DENERVATION | M-1 RECEPTOR | A-BETA | PHARMACOLOGY & PHARMACY | HAMSTER OVARY-M1 CELLS | NIGRA PARS COMPACTA | Central Nervous System Agents - therapeutic use | Schizophrenia - metabolism | Antiparkinson Agents - pharmacology | Central Nervous System - metabolism | Muscarinic Agonists - pharmacology | Humans | Muscarinic Agonists - therapeutic use | Receptor, Muscarinic M2 - drug effects | Receptors, Muscarinic - metabolism | Parkinson Disease - drug therapy | Muscarinic Antagonists - therapeutic use | Receptors, Muscarinic - drug effects | Receptor, Muscarinic M1 - drug effects | Muscarinic Antagonists - pharmacology | Parkinson Disease - metabolism | Substance-Related Disorders - metabolism | Receptor, Muscarinic M2 - metabolism | Alzheimer Disease - drug therapy | Receptor, Muscarinic M4 - metabolism | Animals | Receptor, Muscarinic M4 - drug effects | Alzheimer Disease - metabolism | Central Nervous System Agents - pharmacology | Central Nervous System - drug effects | Antipsychotic Agents - pharmacology | Schizophrenia - drug therapy | Substance-Related Disorders - drug therapy | Receptor, Muscarinic M1 - metabolism | Antipsychotic drugs | Antiparkinsonian agents
Journal Article
JOURNAL OF MEDICINAL CHEMISTRY, ISSN 0022-2623, 11/2017, Volume 60, Issue 22, pp. 9239 - 9250
Journal Article
Pflügers Archiv - European Journal of Physiology, ISSN 0031-6768, 1/2012, Volume 463, Issue 1, pp. 89 - 102
Modulation of the standing outward current (I SO) by muscarinic acetylcholine (ACh) receptor (MAChR) stimulation is fundamental for the state-dependent change... 
Sleep/wake activity | Biomedicine | Phospholipid signaling | Human Physiology | K 2P channels | Muscarinic receptor | Thalamic function | channels | SELECTIVE-INHIBITION | PHYSIOLOGY | DOMAIN POTASSIUM CHANNEL | PHOSPHOLIPASE-C | C-DEPENDENT PROCESSES | ALTERNATIVE TRANSLATION INITIATION | TREK-1 | KCNK | NEUROTRANSMITTERS | TASK-1 | K+ CHANNEL | K-2P channels | Oxotremorine - pharmacology | Gene Expression - genetics | Muscarinic Agonists - pharmacology | Lateral Thalamic Nuclei - cytology | Rats, Long-Evans | Receptor, Muscarinic M1 - antagonists & inhibitors | Guanosine Triphosphate - metabolism | Cholinergic Neurons - physiology | Lateral Thalamic Nuclei - physiology | Receptor, Muscarinic M1 - agonists | Phospholipase C beta - antagonists & inhibitors | Muscarinic Antagonists - pharmacology | Oxotremorine - analogs & derivatives | Thalamus - physiology | Sleep - physiology | Action Potentials - drug effects | Guanosine Diphosphate - pharmacology | Membrane Potentials - drug effects | Phospholipase C beta - metabolism | Potassium Channels, Tandem Pore Domain - metabolism | GTP-Binding Protein alpha Subunits, Gq-G11 - genetics | Electrophysiological Phenomena - physiology | Receptor, Muscarinic M3 - metabolism | Potassium Channels, Tandem Pore Domain - genetics | Rats | Cholinergic Neurons - drug effects | Thionucleotides - pharmacology | Membrane Potentials - physiology | Receptor, Muscarinic M3 - genetics | Receptor, Muscarinic M3 - antagonists & inhibitors | Phospholipase C beta - genetics | Action Potentials - physiology | Receptor, Muscarinic M1 - genetics | Patch-Clamp Techniques | Animals | Guanosine Diphosphate - analogs & derivatives | Signal Transduction - drug effects | Potassium Channels, Tandem Pore Domain - antagonists & inhibitors | Muscarine - pharmacology | Thalamus - cytology | Signal Transduction - physiology | Guanosine Triphosphate - antagonists & inhibitors | Receptor, Muscarinic M1 - metabolism | Electrophysiological Phenomena - drug effects | Hydrogen-Ion Concentration | Sleep | Neurons | Acetylcholine | Phospholipids | Phospholipases | G proteins | Membrane proteins | Potassium Channels, Tandem Pore Domain | Neurons and Cognition | Muscarinic Antagonists | Guanosine Diphosphate | Action Potentials | Muscarine | Life Sciences | Phospholipase C beta | Thionucleotides | Thalamus | Guanosine Triphosphate | Pharmaceutical sciences | Gene Expression | Signal Transduction | Cholinergic Neurons | Receptor, Muscarinic M1 | Receptor, Muscarinic M3 | Muscarinic Agonists | Membrane Potentials | GTP-Binding Protein alpha Subunits, Gq-G11 | Electrophysiological Phenomena | Lateral Thalamic Nuclei | Oxotremorine
Journal Article
Life Sciences, ISSN 0024-3205, 05/2007, Volume 80, Issue 24-25, pp. 2303 - 2307
Journal Article
Developmental Neurobiology, ISSN 1932-8451, 05/2012, Volume 72, Issue 5, pp. 713 - 728
Journal Article
Journal of Neuroimmunology, ISSN 0165-5728, 2011, Volume 237, Issue 1, pp. 13 - 22
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 03/2010, Volume 30, Issue 9, pp. 3398 - 3408
Striatal dopamine (DA) and acetylcholine (ACh) regulate motivated behaviors and striatal plasticity. Interactions between these neurotransmitters may be... 
KNOCK-OUT MICE | MEDIATED MODULATION | PRIMATE STRIATUM | M2-MUSCARINIC DRUGS | MIDBRAIN DOPAMINE | LONG-TERM POTENTIATION | AUTORECEPTOR FUNCTION | NICOTINIC ACETYLCHOLINE-RECEPTORS | NEUROSCIENCES | CAT CAUDATE-NUCLEUS | MONKEY STRIATUM | Receptor, Muscarinic M2 - genetics | Synaptic Transmission - physiology | Muscarinic Agonists - pharmacology | Nucleus Accumbens - metabolism | Basal Ganglia - metabolism | Receptor, Muscarinic M2 - drug effects | Electrophysiology | Receptors, Muscarinic - metabolism | Acetylcholine - metabolism | Corpus Striatum - cytology | Corpus Striatum - metabolism | Basal Ganglia - cytology | Receptors, Muscarinic - drug effects | Neostriatum - drug effects | Nucleus Accumbens - cytology | Neostriatum - metabolism | Synaptic Transmission - drug effects | Interneurons - cytology | Receptor, Muscarinic M4 - genetics | Dopamine - metabolism | Organ Culture Techniques | Receptors, Muscarinic - genetics | Receptors, Nicotinic - drug effects | Receptors, Nicotinic - metabolism | Neostriatum - cytology | Presynaptic Terminals - drug effects | Receptor, Muscarinic M2 - metabolism | Mice, Inbred C57BL | Interneurons - drug effects | Receptor, Muscarinic M4 - metabolism | Mice, Knockout | Patch-Clamp Techniques | Animals | Interneurons - metabolism | Receptor, Muscarinic M4 - drug effects | Corpus Striatum - drug effects | Presynaptic Terminals - metabolism | Mice | Nucleus Accumbens - drug effects | Basal Ganglia - drug effects
Journal Article